Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for biote Corp. (BTMD : NSDQ)

• Company Description    BioTE Holdings, LLC is a medical practice-building business within the hormone optimization space. BioTE Holdings, LLC, formerly known as Haymaker Acquisition Corp. III, is based in NEW YORK. Number of Employees: 223

• Price / Volume Information    Yesterday's Closing Price: $1.95 Daily Weekly Monthly 20 Day Moving Average: 180,950 shares Shares Outstanding: 39.55 (millions) Market Capitalization: $77.12 (millions) Beta: 1.71 52 Week High: $4.75 52 Week Low: $1.27 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -7.14% -12.84% 12 Week -7.58% -15.46% Year To Date -25.00% -31.56%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1875 W. WALNUT HILL LN SUITE 100 - IRVING,TX 75038 USA ph: 844-604-1246 fax: 888-496-0394 ir@biote.com https://biote.com

• General Corporate Information    Officers Bret Christensen - Chief Executive Officer and Director Marc D. Beer - Non-Executive Chairman andChairman of the Board Robert C. Peterson - Chief Financial Officer Richard Barrera - Director Mark Cone - Director Peer Information biote Corp. (BJCT) biote Corp. (CADMQ) biote Corp. (APNO) biote Corp. (UPDC) biote Corp. (IMTIQ) biote Corp. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 090683103 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/05/26 Share - Related Items Shares Outstanding: 39.55 Most Recent Split Date: (:1) Beta: 1.71 Market Capitalization: $77.12 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.07 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.36 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/05/26

• Fundamental Ratios P/E Current FY Estimate: 5.42 Trailing 12 Months: 4.43 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 3.36 Price / Sales: 0.41 EPS Growth vs. Year Ago Period: -25.00% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: -8.28% vs. Previous Quarter: -3.17% ROE 03/31/26 - -25.72 12/31/25 - -23.41 09/30/25 - -21.86 ROA 03/31/26 - 15.12 12/31/25 - 14.63 09/30/25 - 15.68 Current Ratio 03/31/26 - 1.29 12/31/25 - 1.22 09/30/25 - 1.01 Quick Ratio 03/31/26 - - 12/31/25 - 0.79 09/30/25 - 0.72 Operating Margin 03/31/26 - 8.29 12/31/25 - 8.51 09/30/25 - 9.25 Net Margin 03/31/26 - 8.29 12/31/25 - 14.07 09/30/25 - 14.72 Pre-Tax Margin 03/31/26 - 12.47 12/31/25 - 19.55 09/30/25 - 15.72 Book Value 03/31/26 - -1.21 12/31/25 - -1.40 09/30/25 - -1.82 Inventory Turnover 03/31/26 - 3.33 12/31/25 - 3.59 09/30/25 - 3.80 Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - -

Powered by Zacks Investment Research ©